Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' reply. Gunn D, Ford A, Farrin A, Spiller R, et al. Aliment Pharmacol Ther 2023;57:1337-1338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gunn D, Ford A, Farrin A, Spiller R, et al. Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' reply. Aliment Pharmacol Ther 2023;57:1337-1338.
PMID: 37161629